Research article · 27 Jan 2017
Conference abstractPublished 27 Jul 2015
Decrease in serum N-terminal pro-N-type natriuretic peptide levels following anti-heart failure treatment predicts good prognosis in chronic heart failure
Cheng Hsin General Hospital, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: N-terminal pro-N-type Natriuretic Peptide (NT-proBNP)is elevated in patients with chronic heart failure (CHF). The present study sought to explore the prognostic value of temporal changes in serum NT-proBNP concentration following treatment for CHF. Methods: Serum NT-proBNP levels were measured at baseline and after 3-month anti-failure treatment in 124 patients with proven symptomatic CHF and left ventricular ejection fraction (LVEF) <40%. Major adverse cardiac events (MACE) including death, heart transplantation or hospitalization with worsening HF during a median follow-up period of 482 days were determined. Patients were divided into 4 groups according to concentrations of NT-proBNP at baseline versus 3 months, with respect to the baseline median: lowÃ? low (stable below median, n=51), highÃ? high (stable above median, n=42), highÃ? low (above to below median, n=20), and lowÃ? high (below to above median, n=11). Survival analysis was used to assess the risk of MACE, with adjustment for baseline NT-proBNP concentrations. Results: Patients whose serum NT-proBNP concentration below median after treatment (highÃ? low) had a similar MACE rate compared with the lowÃ? low patients (5% vs. 26%, P=NS). Patients whose NT-proBNP concentration worsened (lowÃ? high) had a significantly higher risk (46%) than patients in the lowÃ? low group, and indistinguishable from the highÃ? high group (50%). Reducing of NT-proBNP was associated with increase of LVEF (r=-0.369, P<0.001). Conclusions: Serum NT-proBNP concentration was elevated in CHF and fluctuated following the treatment and might be used as a biomarker in the management of CHF patients. Maintaining lower serum NT-proBNP concentration is associated with improving LVEF and better clinical prognosis.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2021
Correlates and Short-Term Prognostic Value of Plasma N-Terminal Pro- Brain Natriuretic Peptide Levels among Heart Failure Patients; in a Wake of COVID-19 Pandemic: A Prospective Cohort Study
Conference abstract · 2 Aug 2020
Association of Left atrial volume index with N-Terminal Pro-b-Type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction
Research article · 2017
Assessment of Human Natriuretic Peptides (B), Human N-Terminal Pro-BNP and Nor-epinephrine as Neurohumoral Markers in Sleep Disordered Breathing among Heart Failure Patients in Upper Egypt
Research article · 2013
N-Terminal Pro-Brain Natriuretic Peptide: Prognostic Potential in End Stage Liver Cirrhosis in a Cohort Free of Heart Failure; an Egyptian Insight
More from this journal
The newest in Journal of Nursing & Care.
Opinion · 29 Dec 2025
Nurses: Key to Infection Prevention and Patient Safety
Opinion · 29 Dec 2025
Holistic Nursing: Compassionate Pain Management Strategies
Perspective · 29 Dec 2025
Nursing Ethics and Legal Responsibilities: A Comprehensive Guide
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nursing & Care
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Ching Yi Chen RN”
- BylineArticles whose byline prints “Wei-Hsian Yin”

